Can a little extra care make a big difference for cancer trial patients?
NCT ID NCT03667378
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study looks at whether adding personalized supportive care (like help with symptoms and emotional concerns) to standard cancer treatment in early-phase trials helps patients talk more openly about their health. About 83 adults with advanced solid tumors that have not responded to standard treatments will take part. The goal is to see if this extra care improves how patients share their worries and expectations with their doctors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMOR CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.